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Pattern formation depends on the acquisition of precise cellular
identities due to the differential expression of transcription factors.
Enhancers within regulatory regions integrate the positive and neg-
ative regulatory signals directing gene transcription. Here, we ana-
lyze the enhancer that drives expression of the Drosophila gene spalt
in the wing blade. This enhancer integrates positive signals, mediated
by the Decapentaplegic signaling effector protein Medea, with the
repressor activity of Brinker. The enhancer functions in the absence of
binding sites for the wing-specific factor Scalloped. The molecular
analysis of this enhancer indicates that there are additional factors yet
unknown involved in the activation of spalt in the wing blade and
that the mechanism of repression by Brinker does not rely on com-
petition with Mad–Medea overlapping sites. The comparisons with
other enhancers that respond to Decapentaplegic suggest that there
are different possibilities to integrate the positive and negative inputs
triggered by this signaling pathway.
In the Drosophila wing blade, Decapentaplegic (Dpp), a mem-ber of the transforming growth factor- superfamily, controls
the patterning of the veins, through the regulation of different
downstream genes (for comprehensive reviews on the Dpp
pathway and vein patterning, see refs. 1 and 2). Briefly, secreted
Dpp forms a gradient and binds to membrane receptors that
propagate the signal via phosphorylation of Mothers against dpp
(Mad). This protein binds to Medea (Med), and the Mad–Med
complexes translocate to the nucleus, where they regulate tran-
scription. Brinker (Brk), a repressor of Dpp target genes, is
expressed in the most lateral parts of the wing blade, while it is
repressed in the central part of the wing by Schnurri (Shn), a zinc
finger transcription factor that forms complexes with Mad and
Med (3). Thus, Brk repression depends on Dpp, and, at the same
time, it represses Dpp target genes. It has been proposed that Brk
displaces the activator Mad from target sequences (4–6).
The role of Dpp on wing and vein patterning is mainly
mediated by the Spalt (Sal) zinc finger transcription factors (7,
8). The expression of sal in the wing blade is strictly dependent
on Dpp signaling and occurs in a broad central domain that
covers from the L2 provein until the anterior limit of the L5
provein (Fig. 1C). Thus, dpp mutant discs, or clones of cells
mutant for the Dpp receptor Thick veins (Tkv), completely lose
sal expression (7, 9, 10). Two main inputs of Dpp signaling have
been identified affecting sal expression. First, Brk represses sal
expression, and Dpp is necessary to repress brk expression in the
central domain of the wing by means of Shn–Mad–Med com-
plexes. A second input of Dpp is necessary to reach normal levels
of sal expression and occurs independently of Brk. Thus, tkvbrk
and madbrk double mutant clones, which lack at the same time
the repressor (Brk) and the activators of the pathway (Tkv or
Mad), still express sal, although at levels lower than normal
(11–13). These observations indicate that some activators of sal
expression are operative in the absence of Dpp signaling. It has
been proposed that this activation is provided by Vestigial (Vg),
a factor essential for wing and haltere disc development (14–16).
Vg forms complexes with Scalloped (Sd) that bind DNA in a
sequence-specific manner to regulate the expression of down-
stream genes (17–19).
sal genes show a complex pattern of expression regulated by
independent enhancer regions (20, 21). Here, we characterize a sal
wing blade-specific enhancer that includes all the information
needed to generate the sal expression domain in the wing. This
enhancer contains Brk binding sequences, responsible for the
repression of sal in the lateral regions of the wing, and activator
sequences that drive reporter gene expression in the sal domain.
Because activation and repression regions do not overlap, a mech-
anism based on Mad displacement by Brk is, in this case, unlikely.
Med and Sd bind to the activation region, although mutations in
their binding sites do not abolish reporter expression. Furthermore,
endogenous sal is still expressed in wing discs mutant for vg. Taken
together, these results identify a region mediating Brk repression
and corroborate that other wing-specific inputs beyond Mad–Med
and Vg–Sd contribute to the activation of sal expression.
Materials and Methods
Drosophila melanogaster Strains and Clonal Analysis. Flies were
raised on standard Drosophila medium at 25°C. Wing discs
lacking vg were generated in larvae of genotype P[Gal4–638];
FRT42D vgnullFRT42D M (2)l2P[arm-lacZ]; UAS-FLP. vgnull
mutants are described in ref. 22. Wing discs lacking sal and salr
expression in the wing blade were generated in larvae of
genotype P[Gal4–638]; FRT40 Df(2L)32FP-5FRT40 M (2)z
P[arm-lacZ]; UAS-FLP (20). The Gal4 line 638 is expressed only
in the wing blade (data not shown). We also used the UAS-sal
(7) and nubbin (nub)-Gal4 (23). Information about strains not
described in the text and balancer chromosomes can be found in
Flybase (http://f lybase.bio.indiana.edu).
Immunohistochemistry. Immunohistochemistry was performed in
third-instar larval imaginal wing discs following standard pro-
cedures using rat anti-Sal (dilution 1:200) (24), rabbit anti--
galactosidase (-gal) (dilution 1:200; Cappel), and anti-Vg an-
tibodies (dilution 1:200) (16). Fluorescent secondary antibodies
were from Jackson ImmunoResearch and were used at a final
1:200 dilution. Samples were analyzed in a Bio-Rad confocal
microscope. The areas of -gal and Sal expressions were quan-
tified by using the histogram tool of PHOTOSHOP software
(Adobe Systems, Mountain View, CA). The areas of -gal
expression were normalized to the endogenous Sal expression
for each disc. Measurements were taken at least three times on
independent immunostainings, and graphics were generated by
using Microsoft EXCEL.
Abbreviations: -gal, -galactosidase; EMSA, electrophoretic mobility-shift assay.
Data deposition: The sequence reported in this paper has been deposited in the GenBank
database (accession no. AJ578459).
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DNA Binding Assays. Recombinant proteins expressed in bacteria
were used in the electrophoretic mobility-shift assays (EMSAs).
M. Frasch provided MED DNA binding fragments, and band-
shifts were performed as described (25). M. Affolter provided
Brk-expressing construct, and bandshifts were according to
ref. 6. Sd full-length expressing clone was provided by J. B. Bell
(19), and bandshifts were done as described (17). Oligonucle-
otides were labeled radioactively with T4 polynucleotide ki-
nase, hybridized with the corresponding complementary oli-
gonucleotide, and purified in acrylamide gels. The sequences
for oligonucleotides 34, 34c2, 115, and 115c1 are indicated in
Figs. 2 and 5. The sequences for oligonucleotides 274, 274aaa,
413, 413t5, 429, and 429t6 are indicated in Figs. 3 and 5.
Oligonucleotides 311, 311aa, 311tt, and 311.8n appear in Figs.
4 and 5.
Analysis of the Regulatory Regions and Generation of Mutant DNA.
Genomic DNA was cloned in the enhancer tester vector C4PLZ
(26). The constructs were introduced in the germ line by
P-element transformation as described (27). The reporter ex-
pression was detected by immunostaining of third-instar larvae.
For each construct, at least three independent lines were ana-
lyzed. For mutagenesis, we used the QuikChange site-directed
mutagenesis kit (Stratagene). Mutations introduced in the
salEPv enhancer are indicated in the figures. Altered nucleo-
tides are indicated in lowercase. Mutation 413  429 is 5-
TGGATGTTTCGTaAGaGGtTtTtTttCGTTTtTtAAACTG-
TCATA-3. To generate the deletion 143–256, a new SphI
restriction site was created by PCR using the oligonucleotides
1()EcoRI (5-CGAATTCGCGGAACTTCCAAG-3) and
124()SphI (5-TCGAGCATGCACGAAGGAACTGCCTA-
Fig. 1. Characterization of the sal wing blade-specific enhancer. (A) Phenotypic consequences of changes in sal and salr expression in adult wings. (Left) When
both genes are absent (sal, salr), vein L2 does not form and L4 and L5 are fused. The intervein regions L23 and L45 disappear. (Right) When sal is expressed
in the whole wing blade (UAS-salnub-Gal4), the veins L2 and L5 do not form, and the size of the wing is reduced. (B) Immunostaining showing Sal expression
in a wild-type third-instar wing imaginal disc. Vein L2 forms in the anterior compartment in the region, where sal is expressed at low levels. The high levels of
Sal coincide with the presumptive veins L3 and L4. In the posterior compartment, sal expression is adjacent to the presumptive vein L5. (C) Schematic
representation of the anteroposterior axis of the wing blade. Phosphorylated Mad (pMad) colocalizes with high levels of Sal protein in the presumptive veins
L3 and L4. pMad and sal are less abundant at the anteroposterior border. Brk overlaps with the regions of low levels of expression of sal. (D) Genomic region
surrounding the sal transcript (gray boxes) according to Ku¨hnlein et al. (21). Below, close-up of the 1.8-kb DNA fragment that contains the sal wing blade
enhancer, indicating the relevant restriction enzymes used in our analysis. The oligonucleotides used in EMSA experiments are shown below, as well as the
constructs sal328 and salEPv-143–256. In the lower part, gray bars indicate the DNA fragments cloned in front of the reporter gene lacZ. EcoRI–PvuII
corresponds to the salEPv enhancer. (E) Measurements of the areas of -gal expression relative to the endogenous sal expression domain. Gray tones and
numbers are according to D. Bars represent mean values and standard errors. Eliminating the EcoRI–SphI fragment increases the -gal area by 21%. Eliminating
the AseI–PvuII region also increases the -gal area by 20%. (F) Third-instar wild-type wing imaginal discs stained with anti-Sal and anti--gal antibodies. The
pictures show only the anti--gal single channels. Abbreviations for restriction enzymes: E, EcoRI; Pv, PvuII; R, RsaI; S, SalI; Xm, XmnI.
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AGCG-3). The resulting fragment was cloned into the EcoRI–
SphI sites of salEPv.
DNA Comparison and Sequence Analysis. For DNA analysis, we used
the GCG package (Wisconsin University) and BLASTN (National
Center for Biotechnology Information). salEPv enhancer Eu-
ropean Molecular Biology Laboratory accession number is
AJ578459. For transcription factor binding site prediction, we
used MATINSPECTOR (Genomatix).
Results
Characterization of the sal Wing Blade-Specific Enhancer. The ex-
pression of sal in the wing blade is regulated at the level of
transcription, and changes in the expression domain bring about
major morphological consequences (7). Thus, when sal and salr
are absent from the entire wing blade, the vein L2 does not form
and the intervein regions L23 and L45 disappear, causing an
anterior shift of the L3 and L5 veins (Fig. 1 A). When sal is
ectopically expressed in the whole wing blade, the veins L2 and
L5 do not form and the size of the wing is reduced (Fig. 1 A) (8).
The normal domain of sal expression coincides with the region
where Dpp signaling is active, as revealed by the presence of
phosphorylated Mad (pMad; Fig. 1 B and C) (28). The lateral
regions of low expression of sal are partially coincident with the
expression of the brk– lacZ reporter (Fig. 1C) (11).
A fragment of genomic DNA 1.8 kb long, sal1.8SE, located
5 of sal, drives the expression of lacZ in the sal wing blade
domain (data not shown) (21). By cutting down the original
sal1.8SE fragment, we generated the construct salEcoRI–PvuII
that reproduces the sal endogenous expression and is not
detected in the lateral parts of the blade (Fig. 1 D, row 1, E, lane
1, and F, image 1). The expression of -gal is prominent in the
lateral regions of the Sal domain, where sal is normally expressed
at low intensity; this is likely due to the lifespan of the reporter
protein. The constructs salEcoRI–AseI and salEcoRI–NdeI,
which lack the AseI–PvuII and NdeI–PvuII regions, respectively,
expand the reporter expression laterally (Fig. 1 D, rows 2 and 3,
E, lanes 2 and 3, and F, images 2 and 3). When we eliminated the
EcoRI–SphI region from these constructs, generating the sal-
SphI–PvuII, salSphI–AseI, and salSphI–NdeI constructs, the ex-
pression of lacZ expanded further laterally (Fig. 1 D, rows 4–6,
E, lanes 4–6, and F, images 4–6).
Two main conclusions emerge from this analysis. First, the
region responsible for the activation of the reporter is located in
the 197-bp-long SphI–NdeI fragment. Second, the repression of
the reporter in the lateral regions of the blade resides in the
EcoRI–SphI and NdeI–PvuII fragments. All of the necessary
activator and repressor sequences would be included in the
salEcoRI–PvuII construct (henceforth referred to as salEPv).
Brk Represses the Expression of salEPv in the Lateral Regions of the
Wing Blade. Brk is the main repressor of sal in the most lateral
parts of the wing blade. To analyze whether Brk repression is
direct, we examined the binding of Brk protein to probes along
the salEPv enhancer (data not shown). The EcoRI–SphI frag-
ment contains three consensus GGCG(ct)(ct) sequences (6).
From these, only sequences 34 and 115 are able to bind Brk in
Fig. 2. Brk is responsible for the repression of salEPv in the lateral regions
of the wing blade. (A and B) EMSA experiments using radioactive oligonucle-
otides and bacterially expressed Brk protein at increasing concentrations. The
sequences of the oligonucleotides used as probes and competitors are indi-
cated under each panel. The Brk consensus binding sites are shaded in gray.
Nucleotides mutated are indicated in lowercase. An open arrow indicates
changes in mobility, whereas an arrowhead indicates the free probes. (A)
Oligonucleotide 34 labeled radioactively shifts in the presence of recombinant
Brk (). The binding is competed for by increasing quantities of unlabeled
wild-type oligonucleotide 34 (C). The mutant oligonucleotide 34c2 competes
with the binding less efficiently (c2). (B) Oligonucleotide 115 binds recombi-
nant Brk (). Wild-type cold oligonucleotide 115 competes for the binding (C),
whereas mutant 115c1 does not (c1). (C) -gal expression driven by mutant
salEPv enhancers in third-instar imaginal discs. Sal expression in the same
discs is not shown. (D) Measurements of the areas of -gal expression in
relation to the endogenous sal expression. Note that mutation 115c1 increases
-gal expression area by 21%, whereas mutation 34c2 has a milder effect.
When both sites are mutated, the reporter expression area increases similarly
to single 155c1 mutant.
Fig. 3. Med contributes to salEPv enhancer expression in certain regions of
the wing blade. (A and B) EMSA experiments using radioactive oligonucleo-
tides and bacterially expressed Med protein at increasing concentrations. The
sequences of the oligonucleotides used as probes are indicated under each
panel. The sequence consensus for Mad–Med binding is shaded in gray. The
mutated nucleotides are indicated in lowercase. Open arrows indicate Med
binding, whereas open arrowheads indicate the free probe. (A) Med binds to
oligonucleotides 274, 413, and 429. (B) Mutated oligonucleotides 274aaa,
413t5, and 429t6 do not bind Med. (C) Expression of -gal in third-instar discs
driven by mutant salEPv enhancers. (D) Measurements of the areas of -gal
expression in relation to endogenous sal expression. The anteroposterior
extension of the -gal domain in the different mutants does not change in
respect to the salEPv control.














vitro (Fig. 2 A and B and data not shown). The binding is
competed for by wild-type oligonucleotides but not by the
mutated forms 34c2 and 115c1 (Fig. 2 A and B). Furthermore,
Brk does not bind to 34c2 and 115c1 mutant oligonucleotides
(data not shown). The fragment AseI–PvuII contributes to the
repression of the reporter in the lateral regions of the blade
(compare Fig. 1E, lanes 1 to 2 or lanes 4 to 5). This fragment
contains two GGCG(ct)(ct) sequences that show low affinity
for Brk in vitro under our experimental conditions (data not
shown). The mechanism of repression exerted through the
AseI–PvuII fragment remains unexplored.
To analyze the functionality of the 34 and 115 Brk sites in vivo,
we introduced the 34c2 or 115c1 mutations in the salEPv
construct by directed mutagenesis and analyzed the salEPv-
34c2 and salEPv-115c1 constructs for reporter expression in
transgenic flies. The 115c1 mutation expands the domain of
-gal expression similarly to the elimination of the EcoRI–SphI
fragment (Fig. 2 C and D, compare with Fig. 1 E , lane 4, and F,
image 4). The mutation 34c2 produces a milder lateral expansion
of the reporter gene (Fig. 2 C and D). The two mutations
together produce an expansion similar to the 115c1 mutation
alone (Fig. 2D). In summary, we conclude that Brk can repress
reporter expression in the lateral regions of the blade through
the EcoRI–SphI fragment.
Med Is Necessary for Normal Levels of Expression of salEPv in the
Wing Blade. Dpp signaling is necessary for the activation of sal in
the wing blade. Heteroligomers of Mad and Med transmit the
signaling into the nucleus through their binding to target DNAs.
The SphI–NdeI fragment, which is able by itself to activate
reporter expression in the wing blade and thus should respond
to Dpp signaling (Fig. 1 E and F), contains Mad and Med binding
sequences [CGCCGC(gc)G(ca)C] (25). Oligonucleotides 274,
413, and 429, containing consensus sites, bind Med in vitro (Fig.
3A). When mutated, the resulting oligonucleotides 274aaa,
413t5, and 429t6, lose their capacity to bind Med (Fig. 3B).
To analyze the functional relevance of these Med binding sites,
we introduced the above mutations in the salEPv fragment.
salEPv-274aaa shows -gal expression in a region similar to the
control salEPv (Fig. 3 C and D). Interestingly, the expression of
the reporter is reduced in the regions where Sal is detected at
maximal levels in the wild-type discs, that is the presumptive
veins L3 and L4, where pMad is highly expressed (Figs. 1C and
3C). This effect is not observed when the 413 and 429 sites are
mutated (Fig. 3C). However, when the three sites are mutated
at the same time, salEPv-274aaa  413  429 construct, the
effect of the 274aaa mutation increases (Fig. 3C). None of the
three mutations shows expansion or reduction of expression of
the reporter laterally (Fig. 3D). We conclude that the Med
binding sites analyzed contribute to achieve the correct pattern
of expression of the reporter gene despite the fact that the
reporter is still expressed in the wing blade when these sites are
mutated.
VgSd Function Is Not Required for sal Expression in the Wing Blade.
Previous reports suggested that the VgSd complex is necessary
through DNA interactions for the activation of sal in the wing
blade. It has been shown that a large 10.2-kb region upstream of
sal (sal10.2SC, which includes salEPv and drives the expression
of a reporter gene in a manner similar to sal) depends on Sd for
its expression in the wing blade (21, 29). Moreover, a smaller
fragment of 328 bp (sal328), which is expressed in the lateral
regions of the wing blade, binds Sd in vitro (see Figs. 1D and 5C).
Mutations in this fragment that diminish Sd binding affinity
eliminate the expression of the reporter in the wing blade (29),
suggesting its dependence on Sd expression.
To analyze the relevance of VgSd for the expression of the
reporter, we analyzed the affinity of salEPv enhancer for this
complex. Within the salEPv enhancer, the oligonucleotide 311
contains two Sd consensus sequences able to bind Sd (aCATTcc;
Fig. 4A). We generated different mutant forms of 311 that
abolish (311aa) or greatly diminish (311tt) Sd binding capacity
(Fig. 4A). To analyze the significance in vivo of the described
mutations, we introduced them in the salEPv enhancer and
monitored the expression of -gal in transgenic discs. None of
these mutations eliminates reporter expression in the wing blade
(Fig. 4B). Furthermore, the same mutations that diminish Sd
binding and abolish reporter expression in the sal328 context
(29) do not eliminate expression of salEPv-311.8n (Fig. 4B).
The results exposed above do not support a requirement for
Sd in the regulation of the salEPv wing enhancer. To analyze the
Fig. 4. Sd–Vg complex is not essential for sal expression in the wing blade.
(A) EMSA radiograms of bacterially expressed Sd protein. Wild-type oligonu-
cleotide 311 shifts in the presence of increasing quantities of Sd. Binding is
abolished by mutation 311aa or greatly diminished by mutation 311tt. Below
the panel, the above oligonucleotide sequences are shown, as well as the
sequence of the 311.8n mutant. The mutations are indicated in lowercase. The
AT core from the TEA domain (TEF1, TEC1, ABAA) consensus sequences is
shaded, and arrows indicate the Sd consensus binding sites. Open arrows
indicate Sd binding, whereas open arrowheads indicate the free probe. (B)
-gal expression driven by mutant salEPv in third-instar imaginal discs. Sal
expression in the same discs is not shown. (C) Expression of Sal (green) and Vg
(red) in early third-instar wing imaginal discs with large territories mutant for
vg. Red (C) and green (C) channels are shown in black and white. Despite the
absence of Vg, Sal is expressed in the blade. Orthogonal sections below C
show the remaining Vg-expressing cells (arrow). Around them, sal-expressing
cells appear in a different plane (C, arrowhead).
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requirement for Vg in sal regulation, we generated mutant discs
lacking Vg function in large territories of the wing blade (see
Materials and Methods). Third-instar larval discs that lack Vg are
still able to express sal (Fig. 4C). Similarly, smaller clones lacking
Vg in proximal regions of the wing blade maintain sal expression
(data not shown). These clones are hardly detected in distal
regions of the wing blade because of low viability (L. A.
Baena-Lo´pez, personal communication). Therefore, we con-
clude that lack of Vg function does not eliminate sal expression
in the wing blade.
salEPv Enhancer Is Conserved in Drosophila pseudoobscura. The D.
pseudoobscura homologous sal gene, as well as the salEPv
enhancer homologous region, was identified by BLAST search.
The comparison between salEPv from D. melanogaster versus
D. pseudoobscura shows that the oligonucleotides 34 and 115,
involved in the repression of sal in the lateral regions of the
blade, are highly conserved (Fig. 5A). In D. pseudoobscura, the
Sd binding sequences in oligonucleotide 311 diverge from D.
melanogaster, although the core binding sequences for TEA
domains (TEF-1, TEC1, ABAA) are conserved. The other
regions important for the activation of salEPv in the wing blade,
corresponding to oligonucleotides 274, 413, and 429, are highly
conserved between the two species, which supports their rele-
vance for the activation of sal genes.
Our analysis demonstrates that the SphI–NdeI region (boxed
in green in Fig. 5A) activates reporter expression in the wing
blade, although expanded laterally (Fig. 1 D, row 6, E, lane 6, and
F, image 6). However, the sal328 fragment (shaded in gray in Fig.
5A) drives the expression of the reporter gene only laterally,
despite that it contains the SphI–NdeI region (Fig. 5C). salSphI–
NdeI and sal328 fragments differ only in the nucleotides 143–246,
which include two conserved regions (boxed in Fig. 5A). We
analyzed the relevance of these sequences by removing them
from salEPv enhancer. When analyzed in transgenic larvae,
salEPv-143–256 drives reporter expression in a manner com-
parable to salEPv (Fig. 5B). However, this expression does not
seem homogenous. In conclusion, the conserved boxes in the
region 143–256 are dispensable for the expression of the en-
hancer, although they confer consistency to its activity. Further-
more, the areas shown in our analysis to be relevant for the
activation and repression of the salEPv enhancer are conserved
in D. pseudoobscura.
Discussion
The enhancers are key elements in the regulation of gene
expression, as they integrate activator and repressor signals from
different transcription factors. Thus, the analysis of regulatory
regions helps us to understand the molecular networks behind
developmental decisions. The region that directs sal expression
in the wing blade is especially interesting, as sal plays a funda-
mental role in wing growth and pattern formation and is
transcribed there in response to the Dpp signaling pathway.
General Structure of the Wing Blade sal Enhancer. The starting point
of our analysis is the salEPv enhancer, which drives expression
of a reporter gene in the domain of sal expression. This fragment
can be subdivided into two regions. The EcoRI–SphI fragment
appears to confer repression of sal in the most anterior and
posterior regions of the wing blade. Consequently, elimination of
this region results in the expansion of reporter expression. This
fragment contains two Brk binding sites, and their elimination
abolishes repressor activity, suggesting that Brk acts through
these sites to repress sal transcription. The adjacent region is
necessary for reporter activation in the wing blade, and we
expect it to contain the binding sites for the transcriptional
activators that regulate the endogenous sal gene. The existence
of separate repressor and activator regions within the sal en-
hancer impose several restrictions to possible models of regu-
lation. For example, competition of Mad–Med for Brk binding
Fig. 5. salEPv enhancer is conserved in D. pseudoobscura. (A) Alignment of D. melanogaster (Dm) and D. pseudoobscura (Dp) salEPv enhancers. Only the
EcoRI–NdeI region of the enhancer is shown. Relevant restriction enzymes are shown in green. Oligonucleotides used in this analysis are indicated with a blue
line. The nucleotides mutated in the different experiments are shown in blue. The red line boxes the repressor region, and the green line boxes the region
important for activation. sal328 fragment is shaded in gray. The conserved regions eliminated in the mutant salEPv-143–256 are boxed in gray. Italics and bold
characters indicate consensus sequences for Brk, Med, or Sd. (B) Expression of Sal (green) and -gal (red) in third-instar wing imaginal discs driven by the
salEPv-143–256 fragment. The corresponding red channel is in black and white. (C) Schematic representation of the EcoRI–NdeI fragment, which drives the
reporter expression in the central part of the wing blade. When the EcoRI–SphI fragment is removed, the expression expands laterally (SphI–NdeI). The normal
domain of expression is recovered when the repressor sites are added, albeit the levels of expression are heterogeneous (143–256). However, the elimination
of the repressor sites produces a change in the specificity of the enhancer that now drives reporter expression only in the lateral regions of the wing blade (sal328).














sites as a way to alleviate transcriptional repression is, in this
case, unlikely. Moreover, it is not likely that Brk and Mad–Med
complexes coexist in the same cells in the wing blade.
The Activator Region of the sal Enhancer. Our results show that the
Med binding sites 274 and 413–429 are necessary for the normal
expression of salEPv enhancer, even though when mutated they
do not abolish the enhancer activity. The effects of mutant Med
binding sites are observed only in some wing territories, impli-
cating that sal is regulated distinctly in particular subdomains of
its normal territory of expression.
Sd binding sites have been shown to be required for the
expression of the sal328 fragment in the wing blade (29).
However, in the context of the salEPv enhancer, modifications
that prevent Sd binding do not abolish the activity of the
enhancer. Moreover, the analysis of expression of sal in vg
mutant territories confirms that the SdVg complex is dispens-
able for the expression of sal in the wing blade. This observation
does not exclude that these factors may be important to achieve
normal levels of sal expression.
It is interesting to note that the DNA fragment between
nucleotides 143 and 256 (deleted in the salEPv-143–256
construct) is not necessary for reporter expression, but changes
its specificity (Fig. 5 B and C). Thus, when this fragment is placed
next to the activator segment SphI–NdeI (as is the case for the
sal328 fragment), the reporter is no longer expressed in the
central part of the wing blade but in the sides, where sal is not
normally expressed and where the repressor Brk is expressed
(Fig. 5C). Two DNA boxes within the 143–256 DNA fragment
are conserved between D. melanogaster and D. pseudoobscura.
The possible interaction or interactions mediated by these boxes
confer consistency to the salEPv enhancer. The switch from the
central to the lateral domains of the wing blade mediated by the
143–256 DNA fragment remains unexplored.
Other Enhancers Regulated by Dpp. The study of the regulatory
regions of several Dpp target genes indicates that enhancers
responding to this pathway can be organized in different ways.
The UBX midgut-specific enhancer contains Mad–Med and Brk
overlapping binding sequences (4, 30). In this enhancer, Cre
binding sequences are adjacent to the Mad–Med site, contrib-
uting to the activation of the enhancer. Similarly, the zerknu¨llt
(zen) Dpp responding enhancer contains multiple Mad binding
sites overlapping with Brk binding sites (5). Here, occupancy of
all Mad sites when pMad is highly concentrated is responsible for
activation, whereas occupancy of Brk sites is responsible for
repression. Among the wing blade-specific enhancers studied,
optomotor blind (omb) activator and repressor sequences also
overlap. omb is also repressed by Brk in the lateral parts of the
wing, but it does not need Mad–Med for its activation (12).
Interestingly, point mutations in the Brk binding site abolish
reporter expression in the wing blade, indicating the presence of
overlapping activator sequences (6). In the case of sal, activation
and repression regions are adjacent. Here, activation involves
Med binding but requires additional unknown factors. Thus,
although the identity of the positive regulators driving the
expression of omb or sal is unknown, positive regulatory regions
can be adjacent to repressor regions (sal) or overlap with them
(omb). One fundamental question that arises from this analysis
is the nature of the factor or factors activating sal beyond the Dpp
signaling pathway. At present, we cannot answer this question, as
additional candidate genes involved in the regulation of sal have
not yet been identified. The different mechanisms used to
integrate positive and negative inputs in each Dpp-responding
enhancer probably confer the flexibility necessary to regulate
gene expression in the variety of developmental processes where
Dpp signaling is involved.
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